StockNews.AI · 2 hours
SCHMID Group reported Q2 2026 order intake of €30.7m and revenue of €27.7m, with year-to-date orders at €81.6m and backlog €54.8m. Management raised the full-year order intake guidance to €125-€150m while reaffirming >12% EBITDA margin, though H1 margins are expected to be weaker. The company also closed a $20m convertible note to fund working capital and capacity expansion in China, with full interim results due by August 25.
Guidance increase and funding for capacity expansion suggest stronger growth trajectory; near-term upside potential on Aug 25 interim results, offset by dilution risk from new convertible notes.
Higher 2026 order guidance is a bullish near-term catalyst; however, dilution risk from convertible notes warrants caution.
Earnings